| Class 2 Device Recall BD BBL BCYE Selective Agar with PAV | |
Date Initiated by Firm | June 06, 2013 |
Date Posted | July 24, 2013 |
Recall Status1 |
Terminated 3 on September 03, 2013 |
Recall Number | Z-1804-2013 |
Recall Event ID |
65614 |
Product Classification |
Culture media, selective and differential - Product Code JSI
|
Product | BD BBL BCYE Selective Agar with PAV, Catalog # 297880, packaged in cartons of 10 plates, and labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds***
BCYE Selective with PAV is used in qualitative procedures for isolation of Legionella species from clinical specimen and nonclinical (environmental) samples. It is similar to the Edelstein formula, except that the concentration of polymyxin B is reduced by half, and vancomycin is substituted for cefamandole. |
Code Information |
Lot 3078348 Exp 6/27/13 |
Recalling Firm/ Manufacturer |
Becton Dickinson & Co. BD Diagnostic Systems 7 Loveton Circle Sparks MD 21152-0999
|
For Additional Information Contact | Ms. Gail Claiborne 410-316-4054 |
Manufacturer Reason for Recall | Microbiological identification media may exhibit reduced levels of Vancomycin. |
FDA Determined Cause 2 | Nonconforming Material/Component |
Action | The firm, BD Diagnostic Systems, sent an "URGENT PRODUCT RECALL" letter dated June 2013 to Distributors by fax, US customers via letters by UPS and OUS BD sites via email and teleconference. The letter described the product, problem and actions to be taken. All customers were instructed to discontinue use of the listed product; discard any remaining packages, and complete and return the attached form, whether or not you have any inventory remaining, via Fax to: Attention: Regulatory Compliance, 410-316-4258. BD will issue replacements for the discarded material. It is not necessary to contact BD by telephone to receive replacements.
If you have any questions, call 410-316-4000. |
Quantity in Commerce | 163 cartons |
Distribution | Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|